Does QUIZARTINIB Cause Disease progression? 20 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Disease progression have been filed in association with QUIZARTINIB (VANFLYTA). This represents 5.6% of all adverse event reports for QUIZARTINIB.
20
Reports of Disease progression with QUIZARTINIB
5.6%
of all QUIZARTINIB reports
8
Deaths
6
Hospitalizations
How Dangerous Is Disease progression From QUIZARTINIB?
Of the 20 reports, 8 (40.0%) resulted in death, 6 (30.0%) required hospitalization.
Is Disease progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for QUIZARTINIB. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does QUIZARTINIB Cause?
Off label use (47)
No adverse event (40)
Death (32)
Platelet count decreased (27)
Nausea (25)
Pyrexia (20)
Electrocardiogram qt prolonged (19)
Febrile neutropenia (19)
Product dose omission issue (18)
Infection (17)
What Other Drugs Cause Disease progression?
RITUXIMAB (7,282)
CYCLOPHOSPHAMIDE (7,100)
DOXORUBICIN (6,165)
VINCRISTINE (5,252)
PREDNISONE (5,096)
BEVACIZUMAB (4,653)
DEXAMETHASONE (4,545)
CARBOPLATIN (4,538)
CAPECITABINE (3,808)
ETOPOSIDE (3,776)
Which QUIZARTINIB Alternatives Have Lower Disease progression Risk?
QUIZARTINIB vs RABEPRAZOLE
QUIZARTINIB vs RACECADOTRIL
QUIZARTINIB vs RADIATION THERAPY
QUIZARTINIB vs RADIUM RA-223 DICHLORIDE
QUIZARTINIB vs RALOXIFENE